1. ir S, Reetu K (January 2011).

 "Stress and hormones".  Indian Journal of Endocrinology

and Metabolism.  15  (1): 18–22.  doi:10.4103/2230-
8210.77573. PMC  3079864.  PMID  21584161.
2. ^ Greenwood FC, Landon J (April 1966). "Growth hormone secretion in response to
stress in man".  Nature.  210  (5035): 540–
1. doi:10.1038/210540a0. PMID 5960526. S2CID  1829264.
3. ^ Jump up to:a b c d e Powers M (2005). "Performance-Enhancing Drugs". In Leaver-Dunn D,
Houglum J, Harrelson GL (eds.). Principles of Pharmacology for Athletic Trainers. Slack
Incorporated. pp. 331–332. ISBN 978-1-55642-594-3.
4. ^ Daniels ME (1992). "Lilly's Humatrope Experience".  Nature Biotechnology. 10 (7):
812.  doi:10.1038/nbt0792-812a.  S2CID 46453790.
5. ^ Saugy M, Robinson N, Saudan C, Baume N, Avois L, Mangin P (July 2006). "Human
growth hormone doping in sport". British Journal of Sports Medicine. 40 Suppl 1: i35–
9. doi:10.1136/bjsm.2006.027573. PMC  2657499.  PMID  16799101.
6. ^ "GH1 growth hormone 1 (Homo sapiens) - Gene". National Center for Biotechnology
Information, U.S. National Library of Medicine.
7. ^ "GH2 growth hormone 2 (Homo sapiens) - Gene". National Center for Biotechnology
Information, U.S. National Library of Medicine.
8. ^ Yi S, Bernat B, Pál G, Kossiakoff A, Li WH (July 2002).  "Functional promiscuity of
squirrel monkey growth hormone receptor toward both primate and nonprimate growth
hormones".  Molecular Biology and Evolution.  19  (7): 1083–
92.  doi:10.1093/oxfordjournals.molbev.a004166.  PMID  12082127.
9. ^ Leung KC, Howe C, Gui LY, Trout G, Veldhuis JD, Ho KK (October 2002).
"Physiological and pharmacological regulation of 20-kDa growth hormone". American
Journal of Physiology. Endocrinology and Metabolism. 283 (4): E836–
43.  doi:10.1152/ajpendo.00122.2002.  PMID  12217902.
10. ^ Kohler M, Püschel K, Sakharov D, Tonevitskiy A, Schänzer W, Thevis M (November
2008). "Detection of recombinant growth hormone in human plasma by a 2-D PAGE
method".  Electrophoresis. 29 (22): 4495–
502.  doi:10.1002/elps.200800221. PMID 19003817.  S2CID 22525768.
11. ^ Bustamante JJ, Gonzalez L, Carroll CA, Weintraub ST, Aguilar RM, Muñoz J, Martinez
AO, Haro LS (July 2009). "O-Glycosylated 24 kDa human growth hormone has a mucin-
like biantennary disialylated tetrasaccharide attached at Thr-60".  Proteomics.  9 (13):
3474–88. doi:10.1002/pmic.200800989. PMC  2904392.  PMID  19579232.
12. ^ Bartholomew EF, Martini F, Nath JL (2009). Fundamentals of anatomy & physiology.
Upper Saddle River, NJ: Pearson Education Inc. pp. 616–617. ISBN 978-0-321-53910-6.
13. ^ Jump up to:a b Takahashi Y, Kipnis DM, Daughaday WH (September 1968).  "Growth
hormone secretion during sleep".  The Journal of Clinical Investigation. 47 (9): 2079–
90.  doi:10.1172/JCI105893.  PMC 297368. PMID 5675428.
14. ^ Mehta A, Hindmarsh PC (2002). "The use of somatropin (recombinant growth
hormone) in children of short stature". Paediatric Drugs. 4  (1): 37–
47.  doi:10.2165/00128072-200204010-00005.  PMID  11817985. S2CID  23663131.
15. ^ Natelson BH, Holaday J, Meyerhoff J, Stokes PE (August 1975).  "Temporal changes in
growth hormone, cortisol, and glucose: relation to light onset and behavior".  The
American Journal of Physiology.  229  (2): 409–
15.  doi:10.1152/ajplegacy.1975.229.2.409. PMID 808970.
16. ^ Nindl BC, Hymer WC, Deaver DR, Kraemer WJ (July 2001). "Growth hormone
pulsatility profile characteristics following acute heavy resistance exercise".  Journal of
Applied Physiology.  91  (1): 163–
72.  doi:10.1152/jappl.2001.91.1.163.  PMID  11408427. S2CID  16101442.
17. ^ Juul A, Jørgensen JO, Christiansen JS, Müller J, Skakkeboek NE (1995). "Metabolic
effects of GH: a rationale for continued GH treatment of GH-deficient adults after
cessation of linear growth". Hormone Research. 44 Suppl 3 (3): 64–
72.  doi:10.1159/000184676.  PMID  8719443.
18. ^ Jump up to:a b Gardner DG, Shoback D (2007). Greenspan's Basic and Clinical
Endocrinology(8th  ed.). New York: McGraw-Hill Medical. pp. 193–201. ISBN 978-0-07-
144011-0.
19. ^ Mullington J, Hermann D, Holsboer F, Pollmächer T (September 1996).  "Age-
dependent suppression of nocturnal growth hormone levels during sleep
deprivation".  Neuroendocrinology.  64  (3): 233–
41.  doi:10.1159/000127122.  PMID  8875441.  S2CID 3328167.
20. ^ Lin-Su K, Wajnrajch MP (December 2002). "Growth Hormone Releasing Hormone
(GHRH) and the GHRH Receptor". Reviews in Endocrine & Metabolic Disorders. 3  (4):
313–23. doi:10.1023/A:1020949507265. PMID 12424433.  S2CID 6263928.
21. ^ Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts
GH, Morgan DG, Ghatei MA, Bloom SR (November 2000). "The novel hypothalamic
peptide ghrelin stimulates food intake and growth hormone
secretion".  Endocrinology.  141  (11): 4325–
8. doi:10.1210/endo.141.11.7873.  PMID  11089570.
22. ^ Meinhardt UJ, Ho KK (October 2006). "Modulation of growth hormone action by sex
steroids".  Clinical Endocrinology. 65 (4): 413–22. doi:10.1111/j.1365-
2265.2006.02676.x.  PMID  16984231. S2CID  20688016.
23. ^ Jump up to:a b c Low LC (1991). "Growth hormone-releasing hormone: clinical studies and
therapeutic aspects".  Neuroendocrinology. 53 Suppl 1: 37–
40.  doi:10.1159/000125793.  PMID  1901390.
24. ^ Fedi M, Bach LA, Berkovic SF, Willoughby JO, Scheffer IE, Reutens DC (February
2008). "Association of a nicotinic receptor mutation with reduced height and blunted
physostigmine-stimulated growth hormone release".  The Journal of Clinical
Endocrinology and Metabolism. 93 (2): 634–7. doi:10.1210/jc.2007-
1611.  PMID  18042647.
25. ^ Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME (1982). "Nicotine
from cigarette smoking increases circulating levels of cortisol, growth hormone, and
prolactin in male chronic smokers".  Psychopharmacology.  78  (4): 305–
8. doi:10.1007/BF00433730.  PMID  6818588.  S2CID 37559511.
26. ^ Coiro V, d'Amato L, Borciani E, Rossi G, Camellini L, Maffei ML, Pignatti D, Chiodera P
(November 1984).  "Nicotine from cigarette smoking enhances clonidine-induced increase
of serum growth hormone concentrations in men".  British Journal of Clinical
Pharmacology. 18 (5): 802–5. doi:10.1111/j.1365-
2125.1984.tb02547.x. PMC  1463553.  PMID  6508989.
27. ^ Alba-Roth J, Müller OA, Schopohl J, von Werder K (December 1988).  "Arginine
stimulates growth hormone secretion by suppressing endogenous somatostatin
secretion".  The Journal of Clinical Endocrinology and Metabolism. 67 (6): 1186–
9. doi:10.1210/jcem-67-6-1186. PMID 2903866. S2CID  7488757.
28. ^ Van Cauter E, Latta F, Nedeltcheva A, Spiegel K, Leproult R, Vandenbril C, Weiss R,
Mockel J, Legros JJ, Copinschi G (June 2004). "Reciprocal interactions between the GH
axis and sleep". Growth Hormone & IGF Research. 14 Suppl A: S10–
7. doi:10.1016/j.ghir.2004.03.006. PMID 15135771.
29. ^ Quabbe HJ, Luyckx AS, L'age M, Schwarz C (August 1983). "Growth hormone,
cortisol, and glucagon concentrations during plasma free fatty acid depression: different
effects of nicotinic acid and an adenosine derivative (BM 11.189)".  The Journal of Clinical
Endocrinology and Metabolism. 57 (2): 410–4. doi:10.1210/jcem-57-2-
410.  PMID  6345570.
30. ^ Nørrelund H (April 2005). "The metabolic role of growth hormone in humans with
particular reference to fasting".  Growth Hormone & IGF Research.  15  (2): 95–
122.  doi:10.1016/j.ghir.2005.02.005.  PMID  15809014.
31. ^ Kanaley JA, Weltman JY, Veldhuis JD, Rogol AD, Hartman ML, Weltman A (November
1997). "Human growth hormone response to repeated bouts of aerobic
exercise".  Journal of Applied Physiology.  83  (5): 1756–
61.  doi:10.1152/jappl.1997.83.5.1756.  PMID  9375348.
32. ^ Guillemin R, Gerich JE (1976). "Somatostatin: physiological and clinical
significance". Annual Review of Medicine. 27: 379–
88.  doi:10.1146/annurev.me.27.020176.002115.  PMID  779605.
33. ^ Allen DB (September 1996). "Growth suppression by glucocorticoid
therapy".  Endocrinology and Metabolism Clinics of North America. 25 (3): 699–
717.  doi:10.1016/S0889-8529(05)70348-0. PMID 8879994.
34. ^ Scarth JP (2006). "Modulation of the growth hormone-insulin-like growth factor (GH-
IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging
role for xenobiotic-metabolizing enzymes and the transcription factors regulating their
expression. A review". Xenobiotica; the Fate of Foreign Compounds in Biological
Systems. 36 (2–3): 119–
218.  doi:10.1080/00498250600621627. PMID 16702112.  S2CID 40503492.
35. ^ Jump up to:a b Binder G, Wittekindt N, Ranke MB (February 2007). Noonan Syndrome:
Genetics and Responsiveness to Growth Hormone Therapy.  Horm Res. 67. pp. 45–
49.  doi:10.1159/000097552.  ISBN  978-3-8055-8255-1. S2CID  84531041.
36. ^ "Actions of Anterior Pituitary Hormones: Physiologic Actions of GH". Medical College of
Georgia. 2007. Archived from  the original on 2008-01-11. Retrieved 2008-01-16.
37. ^ Ahmad A, Thomas J, Clewes A, Hokins MT, Guzder R, Ibrahim H, Durham B, Vora JP,
Fraser WD (2003-06-01). "Effects of Growth Hormone Replacement on Parathyroid
Hormone Sensitivity and Bone Mineral Metabolism". The Journal of Clinical
Endocrinology & Metabolism. 88 (6): 2860–2868.  doi:10.1210/jc.2002-
021787. PMID 12788900. Retrieved  10 May  2020.
38. ^ King MW (2006).  "Structure and Function of Hormones: Growth Hormone". Indiana
State University. Retrieved  2008-01-16.
39. ^ T.F. Davies (ed.), A Case-Based Guide to Clinical Endocrinology, 2008, pag.16
40. ^ Artwelle GV, Wislon FG (2008).  New Human Growth Hormone Research. Nova
Publishers. pp. 12–.  ISBN  978-1-60456-438-9.
41. ^ https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021148s049lbl.pdf
42. ^ Jump up to:    Ignatavicius D, Workman L (2015).  Medical-Surgical Nursing: Patient-
a b

Centered Collaborative Care  (8  ed.). Saunders. p.  1267. ISBN 978-1455772551.

43. ^ Jump up to:        Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance
a b c d

ML, Stephens PA (May 2006).  "Evaluation and treatment of adult growth hormone
deficiency: an Endocrine Society Clinical Practice Guideline".  The Journal of Clinical
Endocrinology and Metabolism. 91 (5): 1621–34. doi:10.1210/jc.2005-
2227.  PMID  16636129.
44. ^ Jump up to:a b Prodam F, Caputo M, Belcastro S, Garbaccio V, Zavattaro M, Samà MT,
Bellone S, Pagano L, Bona G, Aimaretti G (December 2012). "Quality of life, mood
disturbances and psychological parameters in adult patients with GH
deficiency". Panminerva Medica.  54  (4): 323–31.  PMID  23123585.
45. ^ Jump up to:a b Nyberg F, Hallberg M (June 2013). "Growth hormone and cognitive
function".  Nature Reviews. Endocrinology. 9  (6): 357–
65.  doi:10.1038/nrendo.2013.78.  PMID  23629538. S2CID  33876345.